Thrombin Peptide Derivative Stability via Dimerization Inhibitors
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Thrombin peptide derivatives, used for promoting angiogenesis and tissue repair, are highly susceptible to dimerization, which reduces their stability and effectiveness over time, making it challenging to maintain their purity and deliver precise dosages.
Innovation Solution
Incorporating a dimerization inhibitor such as a chelating agent or thiol-containing compound, like EDTA or thioglycerol, to prevent dimerization, and optionally using an antioxidant to enhance stability, allowing the thrombin peptide derivatives to retain their monomeric form for extended periods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If thrombin peptide derivatives are stored over time, then their therapeutic activity is maintained, but they undergo dimerization which reduces purity and effectiveness
Solution Approach 1:
A dimerization inhibitor is introduced as an intermediary substance that mediates between the thrombin peptide derivative and the dimerization process. The inhibitor binds to the peptide derivative and prevents self-association into dimers, thereby maintaining monomeric purity while preserving therapeutic activity over extended storage periods
Solution Approach 2:
The chemical environment parameters are modified by adding dimerization inhibitors and adjusting pH conditions. This changes the molecular interaction parameters of the peptide derivative, reducing its propensity to dimerize while maintaining its biological activity, thus resolving the contradiction between stability and reliability
2Duration of action of stationary object
If thrombin peptide derivatives are stored for extended periods, then dosage precision is compromised due to dimerization, but storage life needs to be extended for practical use
Solution Approach 1:
Dimerization inhibitors are added to the pharmaceutical composition during the manufacturing stage, before storage. This preliminary protective action prevents dimerization from occurring during storage, thereby extending storage life without compromising the precision of the monomeric dosage that will be administered to patients
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The use of dimerization inhibitors and antioxidants significantly extends the storage life of thrombin peptide derivatives, enabling precise and reproducible dosages, even after prolonged storage, and enhances their therapeutic effectiveness in promoting angiogenesis, bone growth, and tissue repair.
Implementation Method 1
Dimerization inhibitors include chelating agents and/or thiol-containing compounds
Implementation Method 2
Dimerization inhibitors include chelating agents and/or thiol-containing compounds
Implementation Method 3
An antioxidant can also be used in combination with the chelating agent and/or the thiol-containing compound
Data Source
AI summary
Disclosed are pharmaceutical compositions comprising a thrombin peptide derivatives and a chelating agent and/or a pharmaceutically acceptable thiol-containing compound. The pharmaceutical compositions optionally further comprise an antioxidant. Also, disclosed are methods for activating the non-proteolytically activated thrombin receptor in a subject in need of such treatment. The methods comprise the step of administering an effective amount of a thrombin peptide derivative in the pharmaceutical composition described above.